Abstract
The nervous system and the immune system are intimately connected within an extensive network of anatomical and molecular communications, in which molecules of one system can directly stimulate the other. Immune organs such as the spleen are innervated by sympathetic nerves and immunological and inflammatory responses can be modulated by neuropeptides (Payan, 1986; Sternberg, 1997). In the opposite direction cytokines and cytokine receptors, classically associated with the peripheral immune system, are now known to play important roles in CNS functioning (Hopkins and Rothwell, 1995) and cytokine disbalances are associated with CNS disease (Merrill and Benveniste, 1996). TNF is a pleiotropic cytokine which is believed to play a central role in the pathogenesis of human immune-mediated diseases such as multiple sclerosis (MS) (Raine, 1995), Alzheimers Disease (Meda et al., 1995), bacterial meningitis (Leist et al., 1988), cerebral malaria (Grau et al, 1989), and AIDS dementia complex (Tyor et al., 1992). The cell types that contribute to the local production of TNF within the CNS during the pathogenesis of neuronal disease are resident CNS cells, mainly microglia and astrocytes, and infiltrating cells of the immune system particularly macrophages (Hofman et al., 1989; Selmaj et al., 1991; Canella and Raine, 1995).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Akassoglou K., Probert L., Kontogeorgos G., and Kollias G. (1997). Astrocyte, but not neuron-specific, transmembrane TNF triggers inflammation and degeneration in the CNS of transgenic mice. J. Immunol. 158: 438–445.
Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., and Probert L. (1998). Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models of multiple sclerosis with primary oligodendrogliopathy. J. Path. 153: 801–813.
Aversa G., Punnonen J., and De Vries J.E. (1993). The 26-kD transmembrane form of tumor necrosis factor α on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177: 1575–1585.
Baker D., Butler D., Scallon B.J., O’Neil J.K., Turk J.L., and Feldman M. (1994). Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24: 2040–2048.
Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., and Mattson M.P. (1995). Tumor necrosis factors α and β protect neurons against amyloid β-peptide toxicity: Evidence for involvment of a κ-binding factor and attenuation of peroxide and Ca2+ accummulation. Proc. Natl. Acad. Sci. USA 92: 9328–9332.
Beg A.A. and Baltimore D. (1996). An essential role for NF-κ in preventing TNF-α-induced cell death. Science 274: 782–784.
Birkland T.P., Sypek J.P., and Wyler D.J. (1992). Soluble TNF and membrane TNF differ in their ability to activate macrophage antileishmanial defence. J. Leuk. Biol. 51: 296–299.
Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N, Boiani N, Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. (1997): A metalloproteinase disintergrin that releases tumor-necrosis factor-α from cells. Nature 385: 729–733.
Bonetti B. and Raine C.S. (1997). Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42: 74–84.
Brenner M. (1994). Structure and transcriptional regulation of the GFAP gene. Brain Pathol. 4: 245–257.
Brosnan C.F and Raine C.S. (1996). Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6: 243–257.
Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. (1996). Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2: 788–794.
Canella B. and Raine C.S. (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37: 424–435.
Cheng B., Christakos S., and Mattson M.P. (1994). Tumor necrosis factors protect neurons against metabolicexcitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12: 139–153.
Chung I.Y., Norris J.G., and Benveniste E.N. (1991). Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and resistant rat strains. J. Exp. Med. 173: 801–811.
Dopp J.M., Mackenzie-Graham A., Otero G.C., and Merrill J.E. (1997). Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75: 104–112.
Dowling P, Shang G., Raval S., Menonna J., Cook S., and Husar W. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184: 1513–1518.
D’Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., and Antel J.P. (1996). Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184: 2361–2370.
Engelmann H., Holtmann H., Brakebusch C., Avni Y.S., Sarov I., Nophar Y., Hadas E., Leitner O., and Wallach D. (1990). Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265: 14497–14504.
Erickson S.L., de Sauvage F.J., Kikly K., Carver-Moore K., Pitts-Meek S., Gillet N., Sheehan K.F., Schreiber R.D., Goeddel D.V., and Moore M.W. (1994). Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560–563.
Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. (1997): Axonal damage in acute multiple sclerosis lesions. Brain. 120: 393–399.
Fiore M., Probert L., Kollias G., Akassoglou K., Alleva E., and Aloe L. (1996): Neuro-behavioral alterations in developing transgenic mice expressing TNF-α in the brain. Brain Behav. Immun. 10: 126–138.
Frei K., Eugster H.-P, Bopst M., Constantinescu C.S., Lavi E., and Fontana A. (1997): Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 2177–2182.
Gearing A.J., Beckett P., Christodoulou M., Churchill M., Clements I, Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., and Gordon J.L. (1994): Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 370: 555–557.
Georgopoulos S., Plows D., and Kollias G. (1996): Transmembrane TNF is sufficient to induce localised tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm. 46: 86–97.
Giulian D., Vaca K., and Corpuz M. (1993): Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13: 29–37.
Grau G.E., Piguet P.-F, Vassali P., and Lambert P-H. (1989): Tumor-necrosis factor and other cytokines in cerebral malaria: Experimental and clinical data. Immunol. Rev. 112: 49–70.
Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., and Scheurich P. (1995): The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor. Cell 83: 793–802.
Grilli M., Pizzi M., Memo M., and Spano P.F. (1996): Neuroprotection by aspirin and sodium salicylate through blockade of NF-κ activation. Science 274: 1383–1385.
Herbein G., Mahlknecht U., Batliwalla F, Gregersen P., Pappas T, Butler J., O’Brien W.A., and Verdin E. (1998): Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV pgl20 with chemokine receptor CXCR4. Nature 10: 189–194.
Hofman F.M., Hinton D.R., Johnson K., and Merrill J.E. (1989): Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170: 607–612.
Hopkins S.J. and Rothwell N.J. (1995): Cytokines and the nervous system I:expression and recognition. Trends Neurosci. 18: 83–88.
Hurwitz A.A., Lyman W.D., Guida M.P., Calderon T.M., and Berman J.W. (1992): Tumor necrosis factor α induces adhesion molecule expression on human fetal astrocytes. J. Exp. Med. 1992; 176: 1631–1636.
Ivanov T.R. and Brown I.R. (1992): Interaction of multiple nuclear proteins with the promoter region of the mouse 68kDa neurofilament gene. J Neurosci Res 32: 149–158.
Janzer R.C. and Raff M.C. (1987): Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325: 253–257.
Kinouchi K., Brown G., Pasternak G., and Donner D.B. (1991): Identification and characterization of receptors for tumor necrosis factor-α in the brain. Biochem. Biophys. Res. Comm. 181: 1532–1538.
Kriegler M., Perez C., Defay K., Albert I., and Lu S.D. (1988): A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53: 45–53.
Lassmann H. and Vass K. (1995): Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions? Springer Sem. Immunopathol. 17: 77–87.
Lavi E., Suzumura A., Murasko D.M., Murray E.M., Silberberg D.H., and Weiss S.R. (1988): Tumor necrosis factor induces expression of MHC class I antigen on mouse astrocytes. J. Neuroimmunol. 18: 245–253.
Leist T.P, Frei K., Kam-Hansen S., Zinkernagel R.M., and Fontana A. (1988): Tumor necrosis α in cerebrospinal fluid of during bacterial but not viral meningitis. J. Exp. Med. 167: 1743–1748.
Leist M., Gantner F, Jilg S., and Wendel A. (1995): Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154: 1307–1316.
Lewis M., Tartaglia L.A., Lee A., Bennet L., Rice C., Wong G.H.W., Chen E.Y., and Goeddel D.V. (1991): Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88: 2830–2834.
Lipton S.A. (1997): Janus faces of NF-κ: Neurodestruction versus neuroprotection. Nature Med. 20–22.
Lopez-Cepero M., Garcia-SanzJ.A., Herbert L., Riley R., Handel M.E., Podack E.R., and Lopez D.M. (1994): Soluble and membrane-bound TNF-α are involved in the cytotoxic activity of B cells from tumorbearing mice against tumor targets. J. Immunol. 152: 3333–3341.
Lucas R., Juillard P., Decoster E., Redard M., Burger D., Donati Y., Giroud C., Monso-Hinard C., De Kesel T., Buurman W.A., Moore M.W., Dayer J.M., Fiers W., Bluethmann H., and Grau G.E. (1997): Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27: 1719–1725.
Lucchinetti C.F., Bruck W., Rodriguez M., and Lassmann H. (1996): Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6: 259–274.
Maier H., Budka H., Lassmann H., and Pohl P. (1989): Vacuolar myelopathy with multinucleated giant cells in the aquired immunodeficiency syndrome (AIDS). Light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens. Acta Neuropathol. (Berl.) 78: 497–503.
Martin R., McFarland H.F., and McFarlin D.E. (1992): Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10: 153–187.
Meda L., Cassatella M.A., Szendrel G.I., Otvos L., Baron P., Villalbas M., Ferrari D., and Rossi F. (1995): Activation of microglia cells by β-amyloid protein and interferon-γ. Nature 374: 647–650.
Merrill J. (1991): Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev. Neurosci. 13: 130–137.
Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., and Lane T.E. (1993): Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132–2141.
Merrill J.E. and Benveniste E.N. (1996): Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19: 331–338.
Mitrovic B., Ignarro L.J., Vinters H.V, Akers M.-A., Schmid I., Uittenbogaart C., and Merrill J.E. (1995): Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531–539.
Mohler K.M., Sleath P.M., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., and Weerawarna K., et al. (1994): Protection against a leathal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370: 218–220.
Monteiro M.J., Hoffman P.N., Gearhart J.D., and Cleveland D.W. (1990): Expression of NF-L in both neuronal and nonneuronal cells of transgenic mice: Increased neurofilament density in axons without affecting caliber. J. Cell Biol. 111: 1543–1557.
Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfi J.F., Gardinier M., Barrett T.A., and Miller S.D. (1997): INF-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naïve antigen-specific T cells. J. Immunol. 158: 614–621.
Payan D.G. (1986): Neuroimmunology. Adv. Immunol. 39: 299–323.
Perez C., Albert L, DeFay K., Zachariades N, Gooding L., and Kriegler M. (1990): A non-secretable cell surface mutant of tumor necrosis factor (TNF) kills by cell to cell contact. Cell 63: 251–258.
Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., and Kollias G (1995): Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific tumor necrosis factor α expression. Proc. Natl. Acad. Sci. USA 92: 11294–11298.
Pober J.S. (1988): Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am. J. Pathol. 133: 426–433.
Powell M.B., Mitchell D., Lederman J., Buckmeier J., Zamvil S.S., Graham M., Ruddle N.H., and Steinman L. (1990) Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 6: 539–544.
Raine C.S. (1995): Multiple sclerosis: TNF revisited, with promise. Nature Med. 1: 211–214.
Raine C.S. (1997): The Norton lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77: 135–152.
Raine C.S. (1997): Demyelinating diseases. In: R.L. Davies and D.M. Robertson, eds. Textbook of Neuropathology. Baltimore, Maryland: Williams and Wilkins, 627–714.
Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen F, Althage A., Zinkernagel R., Steinmetz M., and Bluethmann H. (1993): Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798–8
Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., and Clark R.B. (1990): An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. X Exp. Med. 172: 1193–1200.
Sartani G., Silver P.B., Rizzo L.V, Chan C.C., Wiggert B., Mastorakos G., and Caspi R.R. (1996): Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest. Ophthalmol. Vis. Sci. 1996; 37: 2211–2218.
Sarkar S. and Cowan N. (1991): Intrangenic sequences affect the expression of the gene encoding glial fibrillary acidic protein. J. Neurochem. 57: 675–684.
Seelentag W.K., Mermod J.J., Montesano R., and Vassalli P. (1987): Additive effects of interleukin 1 and tumor necrosis factor-alpha on the accummulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J. 6: 2261–2265.
Selmaj K.W., Raine C.S., Cannella B., and Brosnan C.F. (1991): Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87: 949–954.
Selmaj K. and Raine C.S. (1988): Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23: 339–3
Selmaj K., Raine C.S., Farooq M., Norton W.T., and Brosnan C.F. (1991): Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147: 1522–1529.
Selmaj K.W., Farooq M., Norton W.T., Raine C.S., and Brosnan C.F. (1990): Proliferation of astrocytes in vitroin response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144: 129–135.
Selmaj K., Papierz W., Glabinski A., and Kohno T. (1995): Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56: 135–141.
Sharief M.K. and Hentges R. (1991): Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325: 467–472.
Shrikant P. and Benveniste E.N. (1996): The central nervous system as an immunocompetent organ. Role of glial cells in antigen presentation. J. Immunol. 157: 1819–1822.
Sipe K.J., Srisawasdi D., Dantzer R., KelleyK.W., and Weyhenmeyer J.A. (1996): An endogenous 55kDa TNF receptor mediates cell death in a neural cell line. Brain Res. Mol. Brain Res. 38: 222–232.
Solorzano C.C., Ksontini R., Pruitt J., Hess P.J., Edwards P.D., Kaibara A., Abouhamze A., Auffenberg J., Galardy R.E., Vauthey J.N., Copeland E.M., Edwards C.K., Lauwers G.Y., Clare-Salzler M., MacKay S.L., Moldawer L.L., and Lazarus D.D. (1997): Involvment of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J. Immunol. 158: 414–419.
Sternberg E.M. (1997): Emotions and disease: From balance of humors to balance of molecules. Nature Med. 3: 264–267.
Tartaglia L.A., Weber R.F, Figari I.S., Reynolds C., Palladino M.A., Jr., and Goeddel D.V. (1991): The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88: 9292–9296.
Tartaglia L.A., Ayres T.M., Wong G.H., and Goeddel D.V. (1993): A novel domain within the 55 kdTNF receptor signals cell death. Cell 74: 845–853.
Tartaglia L.A., Goeddel D.V, Reynolds C., Figari I.S., Weber R.F., Fendly B.M., and Palladino M.A. (1993): Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151: 4637–4641.
Tchelingerian J.L., Monge M., Le Saux F., Zalc B., and Jacque C. (1995): Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J. Neurochem. 65: 2377–2380.
Tyor W.R., Glass ID., Griffin J.W., Becker PS., McArthur J.C. Bezman L., and Griffin D.E. (1992): Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31: 349–360.
VanAntwerp D.J., Martin S.J., Kafri T., Green D.R., and Verma I.M. (1996): Suppression of TNF-α-induced apoptosis by NF-κ. Science 274: 787–789.
Vidovic M., Sparacio S.M., Elovitz M., and Benveniste E.N. (1990): Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-ã and tumor necrosis factor-α. J. Neuroimmunol. 30: 189–200.
Williams K.C., Ulvestad E., and Hickey WF. (1994): Immunology of multiple sclerosis. Clin. Neuroscience 2: 229–245.
Williams K.C., Dooley N.P., Ulvestad E., Waage A., Blain M., Yong V.W., and Antel J.P. (1995): Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglia-derived cytokine IL-1.1 Neurosci. 15: 1869–1878.
Zajicek J.P., Wing M., Scolding N.J., and Compston D.A.S. (1992): Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 115: 1611–1631.
Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., and Lenardo M.J. (1995): Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348–351.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Akassoglou, K., Kassiotis, G., Kollias, G., Probert, L., Bauer, J., Lassmann, H. (1999). Transgenic Models of Tnf Induced Demyelination. In: Matsas, R., Tsacopoulos, M. (eds) The Functional Roles of Glial Cells in Health and Disease. Advances in Experimental Medicine and Biology, vol 468. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4685-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4685-6_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7121-2
Online ISBN: 978-1-4615-4685-6
eBook Packages: Springer Book Archive